No Data
Tevogen Bio Expands On Microsoft Partnership To Integrate Machine Learning And AI Into Preclinical Processes, Accelerating Drug Development And Reducing Costs; Says "Current Timeline For Drug Development Is 10-12 Years And Costs ~$1B-$3B. Approach Has...
Express News | Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI Into Preclinical Processes, Accelerating Drug Development and Reducing Costs
Tevogen Bio Reports That The Co Has Regained Nasdaq Listing Compliance
Express News | Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company
Alpha Capital Appointed as Exclusive Financial Advisor to CD8 Technology to Secure Funding Up To $50 Million
Tevogen Bio Signs Letter Of Intent With CD8 Technology To Build Up To A $50M R&D And Manufacturing Facility; No Impact On Shareholder Equity
No Data
No Data
Onepunch : Good info!